ADINA Act

The ADINA Act requires drug manufacturers to clearly label human-use drugs containing major food allergens (like peanuts or shellfish) or ingredients derived from gluten-containing grains (wheat, barley, rye). This directly affects drug companies producing such medications by mandating specific allergen disclosure on product labels. The key provision adds new labeling requirements to the Federal Food, Drug, and Cosmetic Act, forcing manufacturers to state both the presence of the allergen and its source. The rule takes effect within two years of the bill's enactment. This policy change ensures consumers with allergies can identify potential risks in prescription and over-the-counter drugs.